Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202001

Expand all

PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE)
500MG;EQ 15MG BASE
Marketing Status: Discontinued

Active Ingredient: METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Proprietary Name: PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG;EQ 15MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202001
Product Number: 001
Approval Date: Feb 13, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE)
850MG;EQ 15MG BASE
Marketing Status: Discontinued

Active Ingredient: METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Proprietary Name: PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 850MG;EQ 15MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202001
Product Number: 002
Approval Date: Feb 13, 2013
Applicant Holder Full Name: TORRENT PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information